Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial

Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record is displayed with details about the PEGPH20 and pembrolizumab trial for metastatic pancreatic cancer, including its design, eligibility requirements, outcome measures, and study locations.
    Difference
    69%
    Check dated 2026-11-11T00:27:06.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:13:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A notice about NIH terminology changes appears above the ClinicalTrials.gov page, and the site revision changes from v3.7.1 to v3.7.2. The requested study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:33:30.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:44:26.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the usual study record content with an inaccessible error screen. The change includes an added 403 header and HTML, and deletions remove the standard study data and navigation.
    Difference
    21%
    Check dated 2026-09-22T23:47:50.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the ClinicalTrials.gov page content. This update is likely administrative and does not change the study information presented to users.
    Difference
    0.0%
    Check dated 2026-09-15T23:56:33.000Z thumbnail image

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.